Literature DB >> 25219708

Allergic contact dermatitis to topical brimonidine tartrate gel 0.33% for treatment of rosacea.

Leah A Swanson1, Erin M Warshaw2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25219708     DOI： 10.1016/j.jaad.2014.05.073

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  The Role of Topical Brimonidine Tartrate Gel as a Novel Therapeutic Option for Persistent Facial Erythema Associated with Rosacea.

Authors:  Andrew William Johnson; Sandra Marchese Johnson
Journal:  Dermatol Ther (Heidelb)       Date:  2015-06-26

Review 2.  Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability.

Authors:  Michael S Anderson; Anish Nadkarni; Leah A Cardwell; Hossein Alinia; Steven R Feldman
Journal:  Patient Prefer Adherence       Date:  2017-07-06       Impact factor: 2.711

3.  The Evaluation of Contact Sensitivity with Standard and Cosmetic Patch Test Series in Rosacea Patients.

Authors:  Hilal Kaya Erdogan; Isil Bulur; Zeynep Nurhan Saracoglu; Muzaffer Bilgin
Journal:  Ann Dermatol       Date:  2018-04-23       Impact factor: 1.444

Review 4.  The role of brimonidine tartrate gel in the treatment of rosacea.

Authors:  J Mark Jackson; Melissa Knuckles; John Paul Minni; Sandra Marchese Johnson; Kevin Tate Belasco
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-10-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.